Literature DB >> 34754699

Isolated Polycystic Liver Disease: A Rare Genetic Disorder.

Habib Y Aldabbab1, Moayad A Hakeem2, Fatimah M Alanazi3, Mohammed A Asiri4, Mohammad F Al Hani5, Rahaf I Alshareef6, Abeer R Alkahtani6, Rahaf F Alfadhli6, Lama Y Alharbi6, Abdulla A Jan6, Mohanned M Alraddadi7, Malak Alshammari8.   

Abstract

Polycystic liver disease is a rare clinical condition that causes portal hypertension. It constitutes a group of disorders with liver lesions resulting from abnormal development of the embryological ductal system. Isolated polycystic disease with the absence of polycystic kidney disease is considered a rare condition. We present the case of a 46-year-old man who presented with epigastric pain and episodes of hematemesis. Abdominal examination revealed enlarged liver. He underwent a computed tomography scan that revealed innumerable cystic liver lesions with the presence of ascites. Further investigations confirmed abnormal liver functions and portal hypertension. Physicians need to consider this diagnosis in the appropriate clinical settings. Extensive involvement of the liver may lead to persistent severe symptoms requiring liver transplantation.
Copyright © 2021, Aldabbab et al.

Entities:  

Keywords:  abdominal pain; case report; genetic disorder; hematemesis; polycystic liver disease

Year:  2021        PMID: 34754699      PMCID: PMC8571733          DOI: 10.7759/cureus.18560

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


Introduction

Epigastric abdominal pain is a common complaint in the emergency department. It typically includes common cardiac, hepatic, biliary, and pancreatic etiologies. However, polycystic liver disease is a rare clinical condition that causes portal hypertension. It constitutes a group of disorders with liver lesions resulting from abnormal development of the embryological ductal system. Polycystic liver disease is usually due to autosomal dominant conditions in adults [1]. However, isolated polycystic disease is rare. Herein, we presented the case of a middle-aged man who presented with epigastric pain and episodes of hematemesis that were eventually diagnosed as isolated polycystic liver disease.

Case presentation

A 46-year-old man presented to the emergency department with abdominal pain for a one-week duration. He reported that the pain was gradually increasing in intensity. The pain was diffuse but mainly located in the epigastrium. It was constant pain and associated with decreased appetite, abdominal distension, and recurrent episodes of vomiting that contains blood. He did not report a report any change in bowel or urinary habits. His past surgical history included a laparoscopic appendectomy; otherwise, he was healthy and did not experience any health issues. He does not drink alcohol or smoke cigarettes. There was no history of liver diseases in the family. On examination, the patient was alert, conscious, and oriented. The general examination appeared normal. His vital signs were as follows: temperature of 37.2℃, heart rate of 120 bpm, respiratory rate of 18 bpm, and blood pressure of 112/70 mmHg. Abdominal examination revealed a distended abdomen with an enlarged liver span. Further, he was noted to have moderate ascites. Cardiorespiratory examination revealed normal findings. Laboratory findings revealed a mild elevation in the liver enzymes with an aspartate transaminase level of 51 U/L and an alanine transaminase level of 67 U/L. The albumin level was 2.9 g/dL and the bilirubin level was 1.3 g/dL. The blood glucose level was within the normal limits. Hematological and other biochemical investigations revealed normal findings (Table 1).
Table 1

Summary of the results of laboratory findings

Laboratory InvestigationUnitResultReference Range
Hemoglobing/dL13.113.0–18.0
White Blood Cell1000/mL8.24.0–11.0
Platelet1000/mL340140–450
Erythrocyte Sedimentation Ratemm/hr.190–20
C-Reactive Proteinmg/dL8.30.3–10.0
Total Bilirubinmg/dL1.30.2–1.2
Albuming/dL2.93.4–5.0
Alkaline PhosphataseU/L5046–116
Gamma-GlutamyltransferaseU/L4515–85
Alanine TransferaseU/L6714–63
Aspartate TransferaseU/L5115–37
Lactate DehydrogenaseU/L150140–280
Blood Urea Nitrogenmg/dL177–18
Creatininemg/dL1.10.7–1.3
SodiummEq/L136136–145
PotassiummEq/L3.63.5–5.1
ChloridemEq/L10598–107
D-Dimerng/mL400220–500
Prothrombin Timesec13.011–13.5
Partial Thromboplastin Timesec3025–35
The patient underwent abdominal ultrasound examination, which showed an enlarged liver with diffuse multiple cysts. The patient was resuscitated with intravenous fluid hydration. Subsequently, he underwent a computed tomography scan of the abdomen, which revealed innumerable, homogeneous, and hypoattenuating cystic lesions in the liver (Figure 1). The portal vein measures 23 mm in diameter. Both kidneys were normal. Given the extensive cystic disease, the patient was referred to a hepatology center for possible liver transplantation.
Figure 1

Computed tomography

Computed tomography image showing innumerable, homogeneous, and hypoattenuating cystic lesions in the liver (L) along with ascites (asterisk)

Computed tomography

Computed tomography image showing innumerable, homogeneous, and hypoattenuating cystic lesions in the liver (L) along with ascites (asterisk)

Discussion

We presented the case of a middle-aged man with isolated polycystic liver disease presenting with abdominal pain and hematemesis. In this condition, the hepatic involvement ranges from limited areas of cystic disease to diffuse hepatic involvement of all segments of the liver. It is an autosomal dominant condition resulting in malformation of the ductal plate of the small intrahepatic ducts. However, there was no family history of liver disease in the family indicating a sporadic form of polycystic liver disease. It is reported that up to 50% of cases are related to mutations in the PRKCSH or SEC63 genes [2]. Several anomalies have been described in patients with polycystic liver disease. These anomalies include biliary hamartoma, Caroli disease, and polycystic kidney disease [3]. In the present case, however, the patient did not have any other association. The typical presentation of polycystic liver disease includes a non-specific, dull abdominal pain, abdominal dimension, shortness of breath, and early satiety. Such symptoms were present in our case. Additionally, the polycystic liver can exert extrinsic compression of the portal vein resulting in portal hypertension. Polycystic liver disease is more prevalent among women. Further, pregnancy and exogenous estrogen use are considered risk factors for this disorder. Hence, some hypotheses suggest a possible hormonal role in the pathogenesis of liver cysts. The management options for polycystic liver disease include medical and surgical approaches. The medical approaches include the use of somatostatin analogs to decrease the size of the hepatic cysts [4]. Additionally, percutaneous aspiration of the cysts may be used. Total hepatectomy or liver transplantation may be considered in severe cases [5]. Generally, patients with polycystic liver disease have a good prognosis and do not exhibit the typical liver cirrhosis pathway. The indication of liver transplantation for these patients is generally related to the severity of symptoms and their impact on the quality of life of patients. The presence of liver cysts along with elevated glucose levels should raise the suspicion of the maturity-onset diabetes of the young (MODY). In type 5, there is a mutation in the HFN1B gene, which plays a key role in the development of multiple organs, including the kidneys, liver, and pancreas. Patients with MODY5 may have pancreatic dysfunction, liver disease, and renal cysts [6].

Conclusions

Isolated polycystic liver disease is a rare clinical entity. Physicians need to consider this diagnosis in patients with abdominal pain, ascites, and enlarged liver, even in the absence of a family history of liver disease. Extensive involvement of the liver may lead to refractory symptoms requiring liver transplantation.
  6 in total

Review 1.  Clinical management of polycystic liver disease.

Authors:  René M M van Aerts; Liyanne F M van de Laarschot; Jesus M Banales; Joost P H Drenth
Journal:  J Hepatol       Date:  2017-11-24       Impact factor: 25.083

Review 2.  Somatostatin analogues for treatment of polycystic liver disease.

Authors:  Tom J G Gevers; Joost P H Drenth
Journal:  Curr Opin Gastroenterol       Date:  2011-05       Impact factor: 3.287

Review 3.  Polycystic liver disease: multimodality imaging for complications and transplant evaluation.

Authors:  Desiree E Morgan; Mark E Lockhart; Cheri L Canon; M Paul Holcombe; J Stephenson Bynon
Journal:  Radiographics       Date:  2006 Nov-Dec       Impact factor: 5.333

4.  Maturity-onset diabetes of the young type 5 a MULTISYSTEMIC disease: a CASE report of a novel mutation in the HNF1B gene and literature review.

Authors:  Juan Camilo Mateus; Carolina Rivera; Miguel O'Meara; Alex Valenzuela; Fernando Lizcano
Journal:  Clin Diabetes Endocrinol       Date:  2020-08-26

5.  Isolated Polycystic Liver Disease: An Unusual Cause of Recurrent Variceal Bleed.

Authors:  Mohammad Saud Khan; Zubair Khan; Toseef Javaid; Jamal Akhtar; Abdelmoniem Moustafa; Amos Lal; Abhinav Tiwari; Mohammad Taleb
Journal:  Case Rep Gastrointest Med       Date:  2018-06-04

Review 6.  Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management.

Authors:  Wybrich R Cnossen; Joost P H Drenth
Journal:  Orphanet J Rare Dis       Date:  2014-05-01       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.